Nurix Therapeutics Inc (NRIX)

Cost of Revenue

$2.14M

Quarterly · Period ending: · USD

NRIX logo

NRIX Cost of Revenue

Latest reported$2.14M
NRIX Quarterly Cost of Revenue ($10.43M → $2.14M)
High-resolution chart · PNG

NRIX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
2,139,000
3,850,000
84,137,000
4,631,000
5,000,000
78,096,000
69,663,000
67,224,000
55,481,000
48,922,000
50,005,000
49,713,000
47,856,000
45,763,000
45,816,000
46,106,000
47,761,000
47,493,000
43,137,000
36,531,000
30,906,000
25,994,000
23,003,000
20,445,000
18,939,000
14,142,000
12,967,000
12,824,000
11,008,000
10,759,000
10,434,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.